Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vladu, Ionela
ZUPREME-1, NCT06662539: Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities	Recruiting	2	480	Europe, US	Petrelintide, ZP8396, Placebo	Zealand Pharma, Parexel	Obesity	11/25	04/26